Re-introduction of India ink microscopy testing as a low-cost laboratory diagnostic for cryptococcosis among HIV-infected patients Infections and Infestations
Conditions
Interventions
Following completion of the pre-implementation phase assessments and local stakeholder adaptation meetings, each study facility will roll out India Ink microscopy for cryptococcosis diagnosis as per t
Sponsors
Tulane University
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Healthcare providers: clinicians attending adult HIV-infected patients in screening or consultation rooms and laboratory technicians
Exclusion criteria
Exclusion criteria: 1. Clinicians attending to pediatric patients 2. Clinicians who are not engaged in HIV/AIDS care and treatment 3. Laboratory technicians who are not engaged in laboratory diagnostic testing for cryptococcosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase opportunity for screening of adult HIV-infected patients suspected of having a cryptococcal disease in study sites measured using microscopy testing with India Ink at one time point | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Empirical treatment practice time among clinicians managing cryptococcal infections measured using record keeping during the sample and information flow 2. Clinician satisfaction with the availability of the tool for clinical decision support measured using an in-depth interview record and a 5-point Likert scale at 9 months of the adaptation-intervention period (the end of the intervention phase) | — |
Countries
Mozambique
Contacts
Public ContactJose Langa
Outcome results
None listed